Biotechnology companies and research institutions are increasingly adopting algal-based expression systems for the production of recombinant proteins, vaccines, enzymes, antibodies, and therapeutic compounds. Algal Protein Expression Systems Market Size and Growth Analysis The Algal Protein Expression Systems Market size is expected to reach US$ 523.52 Million by 2034 from US$...

North America holds a significant share of the inactivated vaccines market due to high vaccination coverage, established healthcare systems, and strong government support for immunization initiatives. Growing awareness of preventive healthcare, continuous vaccine innovation, and increasing efforts to control infectious diseases are expected to support market expansion across the region. The...

North America holds a significant share of the inactivated vaccines market due to well-established healthcare infrastructure, high vaccination coverage, and increasing focus on disease prevention. The region benefits from ongoing advancements in vaccine technologies, favorable regulatory support, and expanding investments in public health initiatives, contributing to steady market growth...

The global viral antigens market is experiencing notable growth due to the increasing prevalence of infectious diseases, rising demand for advanced diagnostic technologies, and expanding investments in vaccine research and development. Viral antigens are widely used in disease detection, immunological research, and therapeutic development, making them an essential component of modern healthcare...